August 6, 2021
Congratulations to Dr. Ryan Hoiland (Postdoctoral Fellow in Drs. Christopher West, Prof. Brian Kwon & Dr. Donald Griesdale’s laboratories) who was awarded a 2 year Craig H Neilsen Foundation Postdoctoral Fellowship to support his research project entitled “A novel targeted vascular approach to mitigate secondary hypoxic injury following traumatic SCI”
A lay summary for the grant can be found at. https://chn.dimensions.ai/details/grant/grant.9714653
August 6, 2021
Congratulations to Dr. Lukas Linde (Postdoctoral Fellow in Dr. Kip Kramer’s lab) who was awarded a 2 year Craig H Neilsen Foundation Postdoctoral Fellowship to support his research project entitled “Less is more: Low concentration topical capsaicin to relieve neuropathic pain in spinal cord injury”
A lay summary for the grant can be found here.
August 6, 2021
Congratulations to Dr. Matthew Wiens who was awarded a Michael Smith Foundation for Health Research Scholar Award to support his research focussed on Smart Discharges to improve post-discharge survival following admission for infection.
Dr. Wien’s research program focuses on understanding and predicting vulnerability of mothers, infants, and children after discharge from hospital, and using this knowledge to develop programs that improve post-discharge outcomes. In the Smart Discharges program, healthcare workers use our data-driven, individualized risk prediction score to identify children at high risk of death or complications after discharge from a hospital following treatment for suspected or proven sepsis infection. This score is used to guide the intensity of a counseling and down-referral program that links the participant to a community-level health provider for monitoring and treatment of their recovery during the post-discharge period.
Smart Discharges to improve post-discharge survival following admission for infection July 1, 2021 – June 30, 2026
My research program focuses on understanding and predicting vulnerability of mothers, infants, and children after discharge from hospital, and using this knowledge to develop programs that improve post-discharge outcomes. In our Smart Discharges program, healthcare workers use our data-driven, individualized risk prediction score to identify children at high risk of death or complications after discharge from a hospital following treatment for suspected or proven sepsis infection. This score is used to guide the intensity of a counseling and down-referral program that links the participant to a community-level health provider for monitoring and treatment of their recovery during the post-discharge period.
My research team works primarily in Uganda, though we are now beginning to apply a “reverse innovation” approach to a Canadian context, where pediatric post-discharge morbidity remains an important component in child-health research, policy and practice.
I am pleased to introduce Dr. Catrina Loucks, who is a new full-time faculty member in our department. This is a position shared jointly with the Department of Pediatrics, and is one of the faculty renewal positions we applied for in 2019. The area of research for Dr. Loucks is the Pharmacogenomics of Pain.
Dr. Loucks completed her training in Alberta and BC, most recently as a post-doctoral fellow in the Department of Pediatrics under the supervision of Dr. Bruce Carleton. Her area of expertise is exploring the functional impacts of genetic mutations using C.elegans as a model to understand how particular genes can lead to human diseases. During her post-doctoral fellowship she has specifically explored how genetic variation contributes to the likelihood of developing drug-related toxicities, especially in childhood cancer treatment. However, she has a particular interest in maternal and child pain management, and will be expanding her current work on the pharmacogenomics of morphine in the pediatric population to adult populations. With the recent discovery of an opioid system in C. elegans that appears relevant to human opioid signaling, Dr. Loucks plans to explore the impact of genetic variants uncovered during her PhD. Her lab will be located in the Division of Translational Therapeutics located on the Children and Women’s campus.
Welcome Dr. Loucks!
Dr. Roanne Preston.
Dr. Donald Griesdale, Associate Professor Anesthesiology and Critical Care Medicine, has had a 2 year extension for his Michael Smith Health Professional Investigator Award.
We are very pleased to report that Dr. John Kramer has received an NSERC Discovery grant.
The neuroaxis of pain: Peripheral transduction to central integration
$ 200,000 (5 years)
This is a candidate’s seminar presentation by Wade Thompson
Title: Making medications fit: towards increased implementation of deprescribing in clinical practice
Click the following link to stream:
https://mediasite.audiovisual.ubc.ca/Mediasite/Play/ca8373c1b9b54aeb84a633aaa9d6d8191d
It is my pleasure to announce that the inaugural UBC Department APT Vice-Chair EDI is Dr. Alana Flexman.
Dr. Flexman is a Clinical Associate Professor in the department, working clinically at St. Paul’s Hospital/Providence Healthcare, where she is also the Director of Research. Dr. Flexman is currently completing an Executive MBA in Healthcare. She is the Associate Editor EDI with the Canadian Journal of Anesthesia, an Associate Editor of the Journal of Neurosurgical Anesthesiology, and the Vice-President of Education and Scientific Affairs for the Society for Neuroscience in Anesthesia and Critical Care (SNACC).
Dr. Flexman will start this new role by pulling together the (new) UBC Department committee of Respectful Environments, Equity, Diversity and Inclusion (REDI).
Congratulations Dr. Flexman, we look forward to working with you in this role.
Thank-you to those of you who helped with the selection process.
Roanne
Congratulations to Dr. Tillie-Louise Hackett who was awarded a Tier 1 Canada Research Chair in Asthma and COPD Lung Pathobiology & Therapeutics and Canadian Foundation for Innovation Funding for Single Cell Imaging Research.
In Canada, over 5.8 million people have asthma and chronic obstructive pulmonary disease (COPD) – diseases for which there is no cure – that make it challenging every day to breathe.
Dr. Tillie Hackett’s research uses ultra-resolution imaging to identify lung disease at its earliest stages that cannot be detected using current clinical tests, to define the cellular and molecular alterations responsible for the disease pathobiology. This research will enable a better understanding of how these lung diseases develop, providing new approaches for prediction and diagnosis, resulting in new treatments to improve the lives of asthma and COPD patients.
https://hackettlab.med.ubc.ca
https://www.hli.ubc.ca/researchers/tillie-hackett/
UBC ANNOUNCEMENT
https://research.ubc.ca/fifteen-new-and-renewed-ubc-canada-research-chairs-announced
GOVERNMENT OF CANADA ANNOUNCEMENT
https://www.canada.ca/en/innovation-science-economic-development/news/2021/06/government-of-canada-makes-major-investment-in-canadian-science-research-and-engineering.html
CRC ANNOUNCEMENT
https://www.chairs-chaires.gc.ca/media-medias/lists-listes/2021/june-juin-eng.aspx
